Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - the adult woman

被引:2
作者
Hagenfeldt, KB [1 ]
机构
[1] Karolinska Hosp, Dept Woman & Child Hlth, Div Obstet & Gynaecol, S-17176 Stockholm, Sweden
关键词
congenital adrenal hyperplasia; congenital; female; surgery; fertility; somatic health; transition;
D O I
10.1016/j.ghir.2004.03.016
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a disease with a varying phenotype depending on the mutation(s) present and the severity of the disease. All children with CAH need to be continuously cared for from birth or early infancy by specialists in paediatric endocrinology and surgery. Complications due to over- or under-treatment with corticosteroids are often seen during adolescence, and these problems often continue into adulthood. For the young woman with CAH, questions about menstruation, sexuality, fertility and the possible necessity of complementary surgery are always important issues that need to be discussed. To meet the needs of the young woman with CAH, it is important that the transition from paediatric to adult care be a process of parallel consultations over several years, always involving an experienced gynaecologic endocrinologist. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S67 / S71
页数:5
相关论文
共 24 条
[1]  
AZZIZ R, 1986, FERTIL STERIL, V46, P1011
[2]   SEXUAL-BEHAVIOR IN ADOLESCENT AND ADULT FEMALES WITH CONGENITAL ADRENAL-HYPERPLASIA [J].
DITTMANN, RW ;
KAPPES, ME ;
KAPPES, MH .
PSYCHONEUROENDOCRINOLOGY, 1992, 17 (2-3) :153-170
[3]   1-stage feminizing genitoplasty: 8 years of experience with 49 cases [J].
Farkas, A ;
Chertin, B ;
Hadas-Halpren, I .
JOURNAL OF UROLOGY, 2001, 165 (06) :2341-2346
[4]  
GROUP JLE, 2002, J CLIN ENDOCR METAB, V87, P4048
[5]   Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia [J].
Gussinye, M ;
Carrascosa, A ;
Potau, N ;
Enrubia, M ;
VicensCalvet, E ;
Ibanez, L ;
Yeste, D .
PEDIATRICS, 1997, 100 (04) :671-674
[6]   Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy [J].
Hagenfeldt, K ;
Ritzén, EM ;
Ringertz, H ;
Helleday, J ;
Carlström, K .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) :667-671
[7]   SUBNORMAL ANDROGEN AND ELEVATED PROGESTERONE LEVELS IN WOMEN TREATED FOR CONGENITAL VIRILIZING 21-HYDROXYLASE DEFICIENCY [J].
HELLEDAY, J ;
SIWERS, BO ;
RITZEN, EM ;
CARLSTROM, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (04) :933-936
[8]  
HOLMESWALKER DJ, 1995, CLIN ENDOCRINOL, V43, P291
[9]   Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency [J].
Jaaskelainen, J ;
Voutilainen, R .
CLINICAL ENDOCRINOLOGY, 1996, 45 (06) :707-713
[10]   Long-term outcome of classical 21-hydroxylase deficiency:: diagnosis, complications and quality of life [J].
Jääskeläinen, J ;
Voutilainen, R .
ACTA PAEDIATRICA, 2000, 89 (02) :183-187